Hepatitis B: to better identify patients eligible for treatment in Africa

Today, hepatitis B can be efficiently treated but the diagnosis tools to assess treatment eligibility are complex and their availability is scarce in Africa. To identify these patients, researchers from the Institut Pasteur in Paris and the Institut Pasteur de Dakar have developed a simple and efficient method that could easily be implemented in resource-limited countries.

Find out more